NCT00684619 2022-08-18
506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
Goethe University
Phase 2 Completed
Clinical Trials
6 trialsNCT00006020 2015-03-06
S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
SWOG Cancer Research Network
Phase 2 Completed
NCT00003635 2013-07-18
506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002970 2013-07-02
506U78 in Treating Patients With Refractory Hematologic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003545 2013-02-05
506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005080 2013-01-16
506U78 in Treating Patients With Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed